28
Tue, Mar
10 New Articles

Researchers at Rensselaer Polytechnic Institute in Troy, N.Y., the University of California, Berkeley, and Solidus Biosciences, Inc. have come up with a biochip technology that would accelerate the drug development safety studies with a simultaneous reduction in the need for animal testing during early experiments.

CRANE ChemPharma Flow Solutions announced the launch of its new BioPharm applications module, an addition to its existing www.cranechempharma.com website.  The new interactive module can be also accessed directly at www.cranebiopharm.com, allowing an easier and faster link to CRANE [Saunders®, ResistoPure®, and DEPA®] flow solutions for global BioPharm and Pharmaceutical markets.  

Scientists from the University of Syracuse chemistry department recently created a new drug delivery system which uses gold nanoparticles with attached DNA designed to bind to Doxorubin, an anticancer drug. The system allows for a large number of drug molecules to potentially be released within or in the close proximity of cancer cells.

Sanofi and its subsidiary Genzyme has announced new data from the TEriflunomide multiple sclerosis oral (TEMSO) phase III trial showing once-daily oral teriflunomide significantly reduced annualized rates of relapses leading to hospitalization. New data also confirmed the safety profile and efficacy of teriflunomide over a six-year period after the initial randomization.

French scientists have developed a novel hepatitis C vaccine that may offer the first effective way to prevent an infection that can cause chronic liver disease and cancer. There is currently no available vaccine for hepatitis C, though some companies are developing so-called "therapeutic vaccines," which are designed to help patients who are already infected.

More Articles ...

Sign up via our free email subscription service to receive notifications when new information is available.
captcha